ArticleBritish journal of cancer2026

ATR inhibition potentiates the antitumor efficacy of HER3-DXd in HER3-positive/HR-positive breast cancer by increasing DNA damage.

Xuemei Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.